Skip to content

Leveraging Social Media to Identify and Connect Teens With Eating Disorders to a Mobile Guided Self-Help Mobile Intervention

Leveraging Social Media to Identify and Connect Teens With Eating Disorders to a Mobile Guided Self-Help Mobile Intervention

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04636840
Enrollment
161
Registered
2020-11-19
Start date
2020-12-18
Completion date
2023-12-18
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eating Disorders

Keywords

mHealth, eating disorders, bulimia nervosa, binge eating disorder, teens, adolescents, social media

Brief summary

Clinical or subclinical eating disorders (EDs) impact 10% of individuals in their lifetime and are marked by significant functional impairment, early mortality, chronicity, and emotional distress. ED symptoms often emerge in adolescence, with peak onset age in the teenage years. Early recognition and treatment of these devastating illnesses are needed to prevent long-term consequences and a chronic course. Most (80%) individuals with EDs, including teens with EDs (TwEDs), do not receive treatment. Due to major barriers to access and to the delivery of treatment for TwEDs, there is a need for a new model of service delivery that can identify and help TwEDs. We demonstrated our ability to harness social media to identify and efficiently recruit large numbers of TwEDs. Our team has successfully developed a guided self-help cognitive behavioral therapy (CBT)-based mobile app for previous studies and have adapted this app to address the specific needs of TwEDs. In proposed study, we will test this updated mHealth intervention, which includes simplified language and tailored content relevant to adolescent issues and a social networking feature designed to facilitate group exchanges. This mHealth intervention will be investigated among 161 TwEDs recruited from Instagram/Facebook to test preliminary efficacy and feasibility of this mHealth intervention to improved eating disorder symptoms among TwEDs not currently engaged in treatment. We will also garnering feedback via a mixed methods approach on the efficiency, technical effectiveness, and satisfaction with mHealth intervention content and features. Participants will be randomized to one of 3 study arms, including a control group (self-help version of the app), a group with access to the coached mobile app only, and a group with access to the coached mobile app plus social networking feature. We hypothesized that those with access to the coached mobile app intervention will have improved ED outcomes in comparison to the control group, and that those with access to the additional social networking feature will have the most improvement in ED symptoms out of all three groups.

Interventions

DEVICESpace From Body and Eating Concerns- Teen

Mobile application with coaching component

Sponsors

Washington University School of Medicine
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH
SilverCloud Health
CollaboratorUNKNOWN
Palo Alto University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* US Resident * Owns or has daily access to an iOS or Android smartphone * English-speaking * Screen Positive for a DSM-5 subclinical/clinical eating disorder other than anorexia nervosa (AN) or at high risk for an eating disorder

Exclusion criteria

* Currently Engaged in eating disorder treatment * Screen Positive for Anorexia Nervosa * Wards of the State or Foster Children

Design outcomes

Primary

MeasureTime frameDescription
Eating Disorder PsychopathologyBaseline, 6 weeks, 3 months, 6 monthsEating disorder psychopathology was assessed using the self-report Eating Disorder Examination Questionnaire (EDE-Q). The EDE-Q Global score was calculated as the mean of the Restraint, Eating Concern, Shape Concern, and Weight Concern subscales (items scored 0-6), with higher scores indicating greater severity of eating disorder symptoms.

Secondary

MeasureTime frameDescription
Quality of Life ScoresBaseline, 6 weeks, 3 months, 6 monthsHealth-related quality of life was assessed using the Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales. The total score ranges from 0 to 100 and is calculated as the mean of all answered items (i.e., sum of transformed item scores divided by the number of items answered), with higher scores indicating better quality of life (fewer problems).
Total Time Spent on the App3 monthsAmong participants who logged in at least once, the total time spent on the app was collected and measured in seconds.

Countries

United States

Participant flow

Recruitment details

Participants were recruited using 1) social media advertisements, 2) National Eating Disorder Association (NEDA) online screen. Eligible individuals who completed online screens were sent a link to an online assent form and continued on to complete the baseline survey. 161 participants started their baseline survey, and 148 completed their baseline survey and were randomized into the trial.

Pre-assignment details

A total of 161 participants started their baseline survey. 13 did not complete their baseline survey and were not enrolled or assigned to a trial arm.

Baseline characteristics

Characteristic
Age, Continuous16.09 year
STANDARD_DEVIATION 0.9
BMI26.40 Kg/M^2
STANDARD_DEVIATION 6.42
Race/Ethnicity, Customized
Race and Ethnicity
Hispanic
9 Participants
Race/Ethnicity, Customized
Race and Ethnicity
Non-Hispanic Black
7 Participants
Race/Ethnicity, Customized
Race and Ethnicity
Non-Hispanic White
69 Participants
Race/Ethnicity, Customized
Race and Ethnicity
Other/Multiple races
13 Participants
Sex/Gender, Customized
Sex assigned at birth
Female
43 Participants
Sex/Gender, Customized
Sex assigned at birth
Intersex
0 Participants
Sex/Gender, Customized
Sex assigned at birth
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 510 / 480 / 49
other
Total, other adverse events
0 / 510 / 480 / 49
serious
Total, serious adverse events
0 / 510 / 480 / 49

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026